Adenoid cystic carcinoma (AdCC) of the salivary glands is characterized by MYB-NFIB or MYBL1-NFIB fusion, prolonged but relentlessly progressive clinical course with frequent recurrences, and development of distant metastasis resulting in high long-term mortality. Currently, no effective therapy is available for patients with advanced non-resectable and/or metastatic disease. Complicating the clinical management of this patient group is the lack of prognostic markers. The purpose of this study is to investigate the prognostic value of 1p36 loss in patients with AdCC. The presence of 1p36 deletion and gene fusions involving the MYB, NFIB, and MYBL1 genes in a cohort of 93 salivary gland AdCCs was studied using fluorescence in situ hybridization. These results were statistically correlated with clinical data and outcome. Deletion of 1p36 in AdCC was identified in 13 of 85 analyzable cases (15.29%). MYB-NFIB fusion was detected in 57/85 (67.1%), MYBL1-NFIB fusion in 12/85 (14.1%), MYB-X fusion in 4/85 (4.7%), MYBL1-X in 4/85 (4.7%), and NFIB-X in 2/85 (2.4%) of AdCC cases. None of the 1p36-deleted samples showed MYBL1 rearrangement. Statistical analysis demonstrated a significant correlation between 1p36 deletion and advanced tumor stage and solid histology (p = 0.0061 and 0.0007, respectively). Kaplan-Meier survival curves showed statistically significant correlations between 1p36 deletion and decreased overall survival, disease-specific survival, recurrence-free interval, and recurrence-free survival, all of which were maintained in multivariate analysis. We demonstrate that 1p36 deletion can serve as an indicator of unfavorable outcome of patients with salivary gland AdCC.

Bioptic Laboratory Ltd Molecular Pathology Laboratory Mikulášské náměstí 4 326 00 Plzen Czech Republic

Department of Maxillofacial Surgery Faculty of Medicine in Plzen Clinic of Dentistry Charles University Plzen Czech Republic

Department of Oral Pathology Faculty of Dentistry University of São Paulo São Paulo Brazil

Department of Otorhinolaryngology and Maxillofacial Surgery Zealand University Hospital Køge Denmark

Department of Otorhinolaryngology Faculty of Medicine in Plzen Charles University Plzen Czech Republic

Department of Otorhinolaryngology Head and Neck Surgery and Audiology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Department of Pathology Faculty of Medicine in Plzen Charles University Plzen Czech Republic

Department of Pathology Rigshospitalet Copenhagen University Hospital Copenhagen Denmark

Zobrazit více v PubMed

Cancer Genet Cytogenet. 2005 May;159(1):89-95 PubMed

Clin Cancer Res. 2011 Nov 15;17(22):7003-14 PubMed

Oral Oncol. 2015 Jul;51(7):652-61 PubMed

Cancer Res. 2008 Apr 15;68(8):2551-6 PubMed

Oncol Rep. 2011 Dec;26(6):1393-8 PubMed

Forum (Genova). 2000 Apr-Jun;10(2):108-18 PubMed

Hepatogastroenterology. 2004 Jan-Feb;51(55):186-91 PubMed

Histopathology. 2017 May;70(6):880-888 PubMed

Am J Surg Pathol. 2017 Oct;41(10):1422-1432 PubMed

Mod Pathol. 2018 Aug;31(8):1211-1225 PubMed

Eye (Lond). 2017 May;31(5):720-725 PubMed

J Natl Cancer Inst. 2017 Sep 1;109(9): PubMed

Proc Natl Acad Sci U S A. 2009 Nov 3;106(44):18740-4 PubMed

Hepatology. 2009 Feb;49(2):513-22 PubMed

Clin Cancer Res. 2010 Oct 1;16(19):4722-31 PubMed

Nat Genet. 2013 Jul;45(7):791-8 PubMed

Oral Oncol. 2016 Jun;57:63-9 PubMed

Oncogene. 1998 Feb 19;16(7):865-72 PubMed

Cancer Res. 2012 Dec 1;72(23):6079-88 PubMed

Am J Pathol. 2013 Jun;182(6):2048-57 PubMed

J Thorac Oncol. 2015 Nov;10(11):1570-5 PubMed

Oncol Rep. 2016 Apr;35(4):2177-82 PubMed

Genes Chromosomes Cancer. 1994 Jun;10(2):115-21 PubMed

Lab Invest. 2008 May;88(5):464-73 PubMed

Am J Surg Pathol. 2011 Jan;35(1):92-9 PubMed

Genes Chromosomes Cancer. 2012 Aug;51(8):805-17 PubMed

J Clin Invest. 2013 Jul;123(7):2965-8 PubMed

Contemp Clin Dent. 2012 Apr;3(2):223-6 PubMed

Hum Pathol. 2014 Nov;45(11):2270-80 PubMed

Arch Pathol Lab Med. 2011 Jan;135(1):123-30 PubMed

J Clin Oncol. 2017 Jan 20;35(3):352-360 PubMed

Cancer Detect Prev. 2000;24(6):620-7 PubMed

Clin Cancer Res. 2016 Feb 1;22(3):725-33 PubMed

Head Neck Pathol. 2013 Jul;7 Suppl 1:S12-9 PubMed

Cancer. 1978 Jul;42(1):265-82 PubMed

Mod Pathol. 2011 Sep;24(9):1169-76 PubMed

Cancer. 1984 Sep 15;54(6):1062-9 PubMed

Am J Surg Pathol. 2018 Feb;42(2):e11-e27 PubMed

Am J Surg Pathol. 2017 Nov;41(11):1473-1482 PubMed

Oral Oncol. 2015 Dec;51(12):1138-42 PubMed

Cancer Discov. 2016 Feb;6(2):176-87 PubMed

J Oral Pathol Med. 2009 Jan;38(1):94-8 PubMed

Cancer Prev Res (Phila). 2016 Apr;9(4):265-74 PubMed

Histol Histopathol. 2003 Jul;18(3):935-42 PubMed

Clin Cancer Res. 2008 Aug 15;14(16):5181-7 PubMed

Anal Cell Pathol (Amst). 2010;33(5):217-28 PubMed

J Mol Diagn. 2006 May;8(2):268-76 PubMed

Am J Ophthalmol. 2006 Jan;141(1):54-61 PubMed

Molecular Profiling of Sinonasal Adenoid Cystic Carcinoma: Canonical and Noncanonical Gene Fusions and Mutation

Sinonasal adenoid cystic carcinomas accompanied by seromucinous hamartoma and/or atypical sinonasal glands arising from seromucinous hamartoma: insight into their histogenesis

Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC-rearranged sarcomas: a study of 48 molecularly confirmed cases

Atypical and worrisome histological features in pleomorphic adenoma: challenging and potentially significant diagnostic pitfall

Next-generation sequencing in the molecular classification of endometrial carcinomas: Experience with 270 cases suggesting a potentially more aggressive clinical behavior of multiple classifier endometrial carcinomas

Uterine sarcoma with KAT6B/A::KANSL1 fusion: a molecular and clinicopathological study on 9 cases

Discovery of Novel TULP4/ACTN4/EWSR1/ACTB::MYB and ESRRG::DNM3 Fusions Expands Molecular Landscape of Adenoid Cystic Carcinoma Beyond Fusions Between MYB/MYBL1 and NFIB Genes

SMARCB1-deficient sinonasal adenocarcinoma: a rare variant of SWI/SNF-deficient malignancy often misclassified as high-grade non-intestinal-type sinonasal adenocarcinoma or myoepithelial carcinoma

Molecularly defined sinonasal malignancies: an overview with focus on the current WHO classification and recently described provisional entities

Molecular pathology in diagnosis and prognostication of head and neck tumors

A minority of cases of acinic cell carcinoma of the salivary glands are driven by an NR4A2 rearrangement: the diagnostic utility of the assessment of NR4A2 and NR4A3 alterations in salivary gland tumors

EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers

"High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases